Literature DB >> 24972726

Synthesis and antibacterial activity of catecholate-ciprofloxacin conjugates.

Sylvain Fardeau1, Alexandra Dassonville-Klimpt1, Nicolas Audic2, André Sasaki3, Marine Pillon1, Emmanuel Baudrin1, Catherine Mullié1, Pascal Sonnet4.   

Abstract

The development of an efficient route to obtain artificial siderophore-antibiotic conjugates active against Gram-negative bacteria is crucial. Herein, a practical access to triscatecholate enterobactin analogues linked to the ciprofloxacin along with their antibacterial evaluation are described. Two series of conjugates were obtained with and without a piperazine linker which is known to improve the pharmacokinetics profile of a drug. A monocatecholate-ciprofloxacin conjugate was also synthesized and evaluated. The antibacterial activities against Pseudomonas aeruginosa for some conjugates are related to the iron concentration in the culture medium and seem to depend on the bacterial iron uptake systems.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial; Iron chelator–ciprofloxacin conjugate; Pseudomonas; Siderophore; Trojan horse strategy

Mesh:

Substances:

Year:  2014        PMID: 24972726     DOI: 10.1016/j.bmc.2014.05.067

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  Esterase-Catalyzed Siderophore Hydrolysis Activates an Enterobactin-Ciprofloxacin Conjugate and Confers Targeted Antibacterial Activity.

Authors:  Wilma Neumann; Martina Sassone-Corsi; Manuela Raffatellu; Elizabeth M Nolan
Journal:  J Am Chem Soc       Date:  2018-04-10       Impact factor: 15.419

Review 2.  Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.

Authors:  Jean Tyrrell; Máire Callaghan
Journal:  Microbiology (Reading)       Date:  2015-12-04       Impact factor: 2.777

3.  Evaluation of a reducible disulfide linker for siderophore-mediated delivery of antibiotics.

Authors:  Wilma Neumann; Elizabeth M Nolan
Journal:  J Biol Inorg Chem       Date:  2018-07-02       Impact factor: 3.358

4.  Anionic fluoroquinolones as antibacterials against biofilm-producing Pseudomonas aeruginosa.

Authors:  Timothy E Long; Lexie C Keding; Demetria D Lewis; Michael I Anstead; T Ryan Withers; Hongwei D Yu
Journal:  Bioorg Med Chem Lett       Date:  2016-01-07       Impact factor: 2.823

5.  Platform to Discover Protease-Activated Antibiotics and Application to Siderophore-Antibiotic Conjugates.

Authors:  Jonathan H Boyce; Bobo Dang; Beatrice Ary; Quinn Edmondson; Charles S Craik; William F DeGrado; Ian B Seiple
Journal:  J Am Chem Soc       Date:  2020-12-10       Impact factor: 15.419

Review 6.  Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules.

Authors:  Joanna Fedorowicz; Jarosław Sączewski
Journal:  Monatsh Chem       Date:  2018-06-07       Impact factor: 1.451

Review 7.  Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs?

Authors:  Kokob H Negash; James K S Norris; James T Hodgkinson
Journal:  Molecules       Date:  2019-09-11       Impact factor: 4.411

Review 8.  Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines.

Authors:  Ghadeer A R Y Suaifan; Aya A M Mohammed; Bayan A Alkhawaja
Journal:  Molecules       Date:  2022-03-03       Impact factor: 4.411

9.  Study of Iron Piperazine-Based Chelators as Potential Siderophore Mimetics.

Authors:  Pauline Loupias; Isabelle Dechamps-Olivier; Laurent Dupont; Pierre Vanlemmens; Catherine Mullié; Nicolas Taudon; Anne Bouchut; Alexandra Dassonville-Klimpt; Pascal Sonnet
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.